end-stage nephropathy
Conditions
Interventions
Group 1:Regular peritoneal dialysis+Oral administration of Niaoduqing Particles
Group 2:Regular peritoneal dialysis
Sponsors
The First Affiliated Hospital of Chengdu Medical College
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged over 18 years male and female; 2. clear consciousness; 3. Regular peritoneal dialysis was performed and the urine volume was > 100ml at 24 hours; 4. Patients with stable condition who insist on regular review of relevant indicators every 3 months; 5. Volunteer to participate in this study and sign the informed consent; 6. Chinese medicine dialectic is the spleen of the spleen or the spleen and blood bruising.
Exclusion criteria
Exclusion criteria: 1. Refused to sign informed consent; 2. Allergic constitution or allergic to a variety of drugs; 3. There are serious digestive tract diseases that affect drug absorption,such as active ulcer,Chronic diarrhea,etc.; 4. A woman who is pregnant or breast-feeding; 5. Inability to cooperate, as with a psychopath; 6. Alcohol or drug abusers; 7. Patients who had been given Niaoduqing Particles before enrollment; 8. Drugs containing rhubarb were used before enrollment or during the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum phosphorus;Parathyroid hormone; | — |
Secondary
| Measure | Time frame |
|---|---|
| hemoglobin;creatinine;blood urea nitrogen;ß2 microglobulin;ferritin;Transferrin saturation;Serum calcium;C-reactive protein; | — |
Countries
China
Contacts
Public ContactShaoqing Wang
The First Affiliated Hospital of Chengdu Medical College
Outcome results
None listed